Table 2.
Author | Journal | Year of publication | Type | Total OF | RVF | VVF | Combined VVF/RVF |
---|---|---|---|---|---|---|---|
Rieger et al. [20] | ANZJOG | 2004 | RVpur | 89 (100%) | 89 (100%) | 0 | 0 |
Rahman et al. [10] | JOG | 2003 | RVpur | 52 (100%) | 52 (100%) | 0 | 0 |
Nafiou et al. [21] | Int J G O | 2007 | VVpur | 104 (100%) | 0 | 104 (100%) | 0 |
Meyer et al. [22] | Am J O G | 2007 | VVpur | 58 (100%) | 0 | 58 (100%) | 0 |
Ijaiya and Aboyeji [23] | WAJM | 2004 | VVpur | 34 (100%) | 0 | 34 (100%) | 0 |
Melah et. al [4] | J OG | 2007 | VVc | 75/80 (93.7) | 0 | 72/80 (90.0) | 8/80 (10%) |
Ahmad et. al [24] | Int J G O | 2005 | VVc | 1,086 (100%) | 0 | 950/1,025 (92.7) | 75/1,025 (1.5) |
Waaldijk [5, 25] | Am J O G | 2004 | VVc | 1,716 (100%) | 0 | 1,505 (87.7) | 211 (12.3) |
Wall et al. [26] | Am J O G | 2004 | VVc | 899/932 (95.5) | 0 | 800/899 (88.9) | 99 (11%) |
Qi Li Ya et al. [27] | Med Afr N | 2000 | VVc | 27/34 (79.4) | 0 | 327/34 (79.4%) | 7/34 (2.1) |
Hilton and Ward [28] | IU J PFD | 1998 | VVc | (2,202/2,389) 92% | 0 | 2,385/2,484 (96.0) | 99/2,484 (4.0%) |
Arrowsmith [29] | J Urol | 1994 | VVc | 93/98 (94.9) | 0 | 86/98 (92.5) | 7/98 (7.5) |
Gueye et al. [30] | Med Afr N | 1992 | VVc | 118/123 (95.9) | 0 | 119/123 (96.7) | 4/123 (3.2) |
Falandry [31] | Press Med | 1992 | VVc | 213/230 (93%) | 0 | 178/230 (77.4) | 52/230 (22.6) |
Holme et al. [7] | Br J O G | 2007 | V/R | 259 (100%) | 4/297 (1.3) | 247/297 (83.2) | 18/247 (7.3) |
Rijken and Chilopora [32] | Int J G O | 2007 | V/R | 379/407 (93.1) | 12/408 (2.9) | 396/408 (97.5) | 29/408 (7.1) |
Jokhio and Kelly [33] | Int J G O | 2006 | V/R | 116 (100%) | 3/116 (2.69) | 103/116 (88.8%) | 5 (4.3) |
Gessessew and Mesfin [8] | Eth M J | 2003 | V/R | 184/193 (95.3) | 9/193 (4.7) | 166/193 (86%) | 16/193 (8.3) |
Harouna et al. [9] | Med Afr N | 2001 | V/R | 52 (100.0%) | 4/52 (7.7) | 45/52 (86.5%) | 3/52 (5.8) |
Int Urogynecol J Pelvic Floor Dysfunct
Among the fistula cases, 79.4% to 100% were related to the obstetric conditions, while the remaining cases estimated as less than 20% were from other causes (Table 2). Among the overall fistula cases, rectovaginal fistula represents 1% to 8%; vesicovaginal, 79% to 100% of cases and combined vesico and rectovaginal fistula, 1% to 23% of cases (Table 2)